Financial incentives and feedback coincide with sustained improvement in breast RT structure naming

Across 12,853 breast RT patients, TG-263 naming compliance increased and remained high after financial incentives were discontinued.

KEY POINTS

  • This retrospective analysis examined 12,853 breast radiotherapy patients across 29 institutions participating in the Michigan Radiation Oncology Quality Consortium between 2018 and 2024. Investigators assessed adoption of AAPM TG-263 standardized structure nomenclature, focusing on whole-breast PTVs, surgical-bed PTVs, the heart and ipsilateral lung using submitted DICOM structure sets.
  • The quality-improvement program combined standardized treatment-planning templates, educational activities, regular compliance reports and financial incentives. Naming compliance contributed to pay-for-performance programs in 2019–2020, while Gold Card status and value-based reimbursement in 2021 incorporated TG-263 adoption. From 2022–2024, compliance continued to be monitored but was no longer tied to these incentives.
  • Compliance with the standardized whole-breast PTV name PTV_Breast_L/R increased from 85.2% in 2018 to 97.1% in 2024 (p<0.0001). Compliance with the surgical-bed target name PTVsb increased from 86.5% to 90.9%, while simultaneous correct naming of both targets increased from 77.2% to 89.4%.
  • The greatest gains coincided with implementation of the target-naming incentive. Whole-breast PTV compliance increased from 87.2% in 2019 to 95.4% in 2020, while surgical-bed compliance increased from 87.0% to 91.7%. Combined compliance peaked at 91.2% in 2021 and remained 89.4% in 2024, suggesting sustained adoption after incentive withdrawal.
  • OAR naming compliance was consistently higher than target naming. Correct heart nomenclature exceeded 99% throughout the study period, while lung nomenclature increased from 97.2% in 2018 to 99.9% in 2024. These findings suggest that target-specific conventions, rather than basic OAR naming, represent a persistent implementation challenge.
  • Institutional practice varied. In 2024, compliance with PTV_Breast_L/R was 91.1% at teaching centers versus 97.7% at non-teaching centers. One institution accounted for 563 of 1,164 noncompliant surgical-bed names (48.4%), frequently using the nonstandard label PTV_Boost_L/R; excluding that center increased surgical-bed compliance from 90.9% to 95.1%.
  • Although adoption improved during the incentive period, the analysis cannot establish that financial incentives independently caused the change. Standardized templates, educational sessions, monthly reports and technical support were implemented alongside reimbursement initiatives, and the findings come from a voluntary regional consortium with healthcare payment arrangements that may not generalize to other systems.

CLINICAL TAKEAWAY

Standardized target and OAR nomenclature can support safer plan review, consistent data extraction, automated planning and multicenter radiation oncology research. This quality-improvement experience suggests that templates, feedback and institutional incentives can achieve sustained TG-263 adoption, but the relative contribution of each intervention remains uncertain.

SOURCE

Practical Radiation Oncology

Browse more research Suggest a correction